Sign In
Buy MNPR
$60.56
-0.700 (-1.14%)
At Close: Jun 03, 2026
JonesTrading Reaffirms Their Buy Rating on T2 Biosystems (TTOO) - Markets
12:31pm, Wednesday, 01'st Jul 2020
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on T2 Biosystems (TTOO – Research Report).
Monopar Therapeutics Inc. (MNPR) (Chicago, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced today that a provisional patent application entitled “Precision Radioimmunotherapeutic
JonesTrading Initiates a Buy Rating on Curis (CRIS) - Markets
12:24pm, Tuesday, 23'rd Jun 2020
JonesTrading analyst Soumit Roy initiated coverage with a Buy rating on Curis (CRIS – Research Report) today and set a
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Armata Pharmaceuticals
We're Excited To See How Monopar Therapeutics (NASDAQ:MNPR) Uses Its Cash Hoard To Grow
11:53am, Wednesday, 17'th Jun 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysts' Top Healthcare Picks: Albireo Pharma (ALBO), Monopar Therapeutics Inc (MNPR) - Markets
05:58pm, Tuesday, 16'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma
Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19
12:25pm, Tuesday, 16'th Jun 2020
Monopar Therapeutics Inc. (MNPR) (Chicago, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced today a 50/50 collaboration to develop potential Radio-Immuno-Therapeutics (RITs) to trea
Monopar Therapeutics (MNPR) Catches Eye: Stock Jumps 11.2%
02:00pm, Tuesday, 09'th Jun 2020
Monopar Therapeutics (MNPR) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
Monopar Therapeutics Reports First Quarter 2020 Financial Results and Business Updates | MarketScreener
01:01pm, Thursday, 07'th May 2020MONOPAR THERAPEUTICS : Results of Operations and Financial Condition (form 8-K) | MarketScreener
01:01pm, Thursday, 07'th May 2020Monopar Therapeutics Reports First Quarter 2020 Financial Results and Business Updates
01:00pm, Thursday, 07'th May 2020
Monopar Therapeutics Inc. (Monopar or the Company) (MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of l
JonesTrading Thinks Monopar Therapeutics Inc’s Stock is Going to Recover
12:07pm, Tuesday, 31'st Mar 2020
In a report released today,
Soumit Roy
from JonesTrading reiterated a
Buy
rating on Monopar Therapeutics Inc (
MNPR
–
Research Report
). The company’s shares closed last Monday at $7.09, close to
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Business Updates
01:15pm, Friday, 27'th Mar 2020
Monopar Therapeutics Inc. (Monopar or the Company) (MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of l
